{
    "nctId": "NCT02666378",
    "briefTitle": "Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer",
    "officialTitle": "Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Cardiotoxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18 years\n* Have histologic diagnosis of breast carcinoma\n* Scheduled to receive standard clinical therapy designed by their treating oncologist\n* Patients should receive anthracycline as part of the recommended treatment\n* Able to give informed consent.\n\nExclusion Criteria:\n\n* Contraindication to contrast CMR including eGFR \\<30 mls/min/1.73m2\n* Uncontrolled serious concurrent illness\n* Pregnancy or breast feeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}